We are live on
!
Find out more
GCM
Glenview Capital Management Portfolio holdings
AUM
$3.98B
1-Year Est. Return
20.52%
This Fund
S&P 500
This Quarter
Est. Return
+9.26%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$10.9B
AUM Growth
–
Cap. Flow
+$10.5B
Cap. Flow
% of AUM
96.3%
Top 10 Holdings %
Top 10 Hldgs %
46.29%
Holding
61
New
61
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$741M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$708M |
| 3 |
HMA
HEALTH MGMT ASSOC INC CL-A
HMA
|
+$475M |
| 4 |
McKesson
MCK
|
+$475M |
| 5 |
Tenet Healthcare
THC
|
+$441M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.95% |
| 2 | Industrials | 10.64% |
| 3 | Technology | 9.72% |
| 4 | Communication Services | 8.55% |
| 5 | Financials | 8.16% |
Similar funds
MAM
USCWA
AI
LWCA
JSW
AS
BWA
BCP
Glenview Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Glenview Capital Management, which disclosed 61 positions worth $10.9B. Its ten largest holdings account for 46% of the portfolio.
Its largest position is LIFE TECHNOLOGIES CORP COM STK (DE): 10,206,878 shares worth $755M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, followed by Industrials and Technology.
- Glenview Capital Management's largest Q2 2013 buy was LIFE TECHNOLOGIES CORP COM STK (DE): 10,206,878 shares worth $755M.
- Glenview Capital Management's ten largest holdings make up 46% of its $10.9B portfolio in Q2 2013.
- Glenview Capital Management disclosed 61 positions in Q2 2013, its first 13F filing on record.
Based on Glenview Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.